Login| Sign Up| Help| Contact|

Patent Searching and Data


Matches 651 - 700 out of 94,726

Document Document Title
WO/2016/061696A1
By this invention, for the first time, a method for high-efficiency generation of gene knockouts in the anaerobic bacterium Clostridium pasteurianum is provided. Clostridium pasteurianum is a bacterium of substantial industrial importanc...  
WO/2016/062836A1
The invention relates to a capsule comprising: an inner phase comprising at least one plant cell, and an outer gel phase that encapsulates the entire inner phase on the periphery thereof, said outer phase comprising at least one surfacta...  
WO/2016/063299A3
The present invention relates to a novel process of isolating and purifying tissue plasminogen activator and its variants more specifically TNK-tPA from CHO cells and describes an industrially applicable, simple, cost effective, robust a...  
WO/2016/064643A1
The current invention provides a recombinant bacterium, the recombinant bacterium being genetically modified to decrease or eliminate the display of lipoteichoic acid (LTA), surface layer protein B (SlpB) and surface layer protein X (Slp...  
WO/2016/062171A1
Provided are genes, coding proteins and uses thereof, gene elements, genes and uses, gene elements, methods for synthesizing odd numbered medium chain aliphatic aldehydes, for synthesizing odd numbered medium chain aliphatic alcohol and ...  
WO/2016/058096A1
A process for manufacturing a biodegradable bioactive film product, the process comprising: a) isolating polyhydroxyalkanoate from a bacterial culture; b) optionally bleaching the polyhydroxyalkanoate; c) dispersing the polyhydroxyalkano...  
WO/2016/060171A1
 The purpose of the present invention is to provide a yeast having an improved capability to produce ethanol from xylose. The present invention provides a transformed yeast in which a xylose utilization gene and enzyme genes of a pento...  
WO/2016/060437A1
The present invention relates to a microorganism of the genus Corynebacterium for producing L-arginine and an L-arginine production method using same.  
WO/2016/059058A1
The invention relates to a method for producing membrane polysaccharides from an organism selected from micro-organisms, unicellular organisms and filamentous fungi, said method comprising at least one step of extracting said membrane po...  
WO/2016/061275A1
This disclosure describes modified photosynthetic microorganisms, including Cyanobacteria that produce carotenoids, including zeaxanthin, astaxanthin, and/or canthaxanthin. The modifications include one or more genetic modifications such...  
WO/2016/060892A1
In one embodiment, an algae cultivation system includes a passive membrane photobioreactor having an interior space in which algae can be cultivated and a porous membrane that separates growth media from the interior space, wherein water...  
WO/2016/061339A1
Disclosed is a method for modifying yeast to enhance yield of the fermentation primary product, and decrease glycerol in fermentation co-products. The method comprises contacting yeast with a benzoic organic salt followed by yeast fermen...  
WO/2016/059541A1
Provided herein are methods of culturing a microorganism. The method includes providing a container comprising one or more microorganisms and medium, wherein the microorganisms and medium form a start volume. The microorganisms and mediu...  
WO/2016/059540A1
Provided herein are methods of culturing a microorganism. The methods include providing a container comprising one or more microorganisms in a medium, which has a first carbon to nitrogen ratio; culturing the microorganisms until the cul...  
WO/2016/061115A1
The present invention relates to the preparation and use in primates of whole organismvaccines in which the MEP pathway is disrupted such that synthesis of HMBPP by the bacterial cells is substantially blocked. The data provided demonstr...  
WO/2016/059262A1
The invention relates to a method for the enrichment of microalgae biomass, in particular of the genus Nannochloropsis, in different polyunsaturated fatty acids, primarily docosahexaenoic acid (22:6n-3, DHA), using oils rich in these fat...  
WO/2016/058097A1
A process for manufacturing a biodegradable polymer filament product, the process comprising: a) isolating polyhydroxyalkanoate from a bacterial culture; b) optionally bleaching the polyhydroxyalkanoate; c) dispersing the polyhydroxyalka...  
WO/2016/056773A2
The present invention relates to a Corynebacterium glutamicum mutant strain having resistance to high-concentration L-glutamine and a method for producing L-glutamine using the same.  
WO/2016/056650A1
The purpose of the present invention is to identify a novel gene that effectively increases plant biomass, and to provide said gene and a use therefor. The present invention provides: a nucleic acid that encodes a protein characterized b...  
WO/2016/056944A1
The invention relates to the microbiological industry, microbiology and biotechnology, and specifically to the production of physiologically active compounds, and concerns the production of a protein, bacteriorhodopsin, by means of mi...  
WO/2016/054792A1
The present invention provides a mutant polypeptide comprising the amino acid sequence of Escherichia coli tetracycline efflux pump A (TetA), and a polynucleotide encoding the polypeptide. The present invention provides a first expressio...  
WO/2016/056662A1
 Provided is a viscosity reducer for a mannan-containing material, whereby the utility of mannan can be enhanced. A viscosity reducer for a mannan-containing material, including a polypeptide provided with an additional sequence in whi...  
WO/2016/056630A1
 A cell culture bag 10 is provided with: a plurality of gas-permeable tubular portions 11 separated from each other by partition walls, the tubular portions 11 having a tubular axis direction directed along a first direction and being ...  
WO/2016/056566A1
Provided are: a transformant that is capable of producing lactic acid at a high productivity without requiring neutralization with an alkaline agent, and has excellent lactic acid production ability and excellent proliferation potency; a...  
WO/2016/056592A1
The present invention addresses the problem of providing a method for efficiently culturing 1,4-dioxane-decomposing bacteria. The solution is to provide a method for culturing 1,4-dioxane-decomposing bacteria characterized by the use of ...  
WO/2016/057654A1
Engineered stable multi-organism (or multi-cell type) communities encapsulated in a media that slows or prohibits certain metabolic functions such as cell division, but maintains other metabolic functions.  
WO/2016/055971A3
Provided herein are novel methods, systems and processes of mapping and assembling sequence reads. Also provided herein are methods, systems and processes of identifying the presence or absence of a genetic variation in a genome of a sub...  
WO/2016/055879A1
The present invention refers to a process designed to increase the production of plant growth-promoting microorganisms of the Bacillus genus, using a culture medium poor in nutrients and with specific environmental conditions, allowing t...  
WO/2016/050861A1
The present invention relates to methods for cultivating a nitrile hydratase producing microorganism, compositions for cultivating a nitrile hydratase producing microorganism, and use of compositions comprising a saccharide and an organi...  
WO/2016/051983A1
The present invention addresses the problem of providing a cell culture medium, particularly a serum-free cell culture medium, in which the cell proliferation efficiency can be improved without requiring the use of feeder cells. Accordin...  
WO/2016/050654A1
Suggested is a culture of Amycolatopsis sp. ATCC 39116 - mutant F33 or mutant F86 which converts ferulic acid into vanillin.  
WO/2016/049918A1
Biomarkers and methods for predicting the risk of a disease related to microbes are provided, in particular coronary artery disease (CAD) or related heart diseases.  
WO/2016/050111A1
Biomarkers for rheumatoid arthritis (RA) are described. RA-associated metagenomic linkage groups (MLGs) have been identified and validated in gut and oral microbiotas. These MLGs are used in systems, methods and products for identifying ...  
WO/2016/053309A1
The invention relates to creped prebiotic tissue products. The tissue products comprise prebiotics in sufficiently high amounts to have a prebiotic effect in use, without negatively affecting tissue product properties, such as tensile st...  
WO/2016/053397A3
This invention relates to metabolically engineered microorganisms, such as bacterial and or fungal strains, and bioprocesses utilizing such strains. These strains enable the dynamic control of metabolic pathways, which can be used to opt...  
WO/2016/049826A1
Use of Bacteroides uniformis in the preparation of a formulation for treatment and/or prevention of coronary artery disease, or for decreasing the level of blood glucose or lipids, or for ameliorating coronary atherosclerotic lesions. An...  
WO/2016/049927A1
Biomarkers and methods for predicting the risk of a disease related to microbes, in particular obesity or related diseases, are provided.  
WO/2016/049937A1
Biomarkers and methods for predicting the risk of a disease related to microbiota, in particular rheumatoid arthritis (RA), are provided.  
WO/2016/049761A1
36849-014 65 7633800.2 ABSTRACT There are provided efficient and cost-effective methods for purifying biomolecules in solution phase using stimuli-responsive protein-polymer conjugates. The protein- polymer conjugates comprise a target b...  
WO/2016/049932A1
The present invention provides biomarkers and methods for predicting the risk of a disease related to microbes, in particular obesity or related diseases.  
WO/2016/053397A2
This invention relates to metabolically engineered microorganisms, such as bacterial and or fungal strains, and bioprocesses utilizing such strains. These strains enable the dynamic control of metabolic pathways, which can be used to opt...  
WO/2016/049879A1
Provided are uses of Bacteroides in preparation of a medicament. The medicament is for use in treatment or prevention of obesity-related diseases. Also provided are a pharmaceutical composition, a medicament, a food product, and an anima...  
WO/2016/050890A3
Methods for recombinant and enzymatic production of mogroside compounds and compositions containing mogroside compounds are provided by this invention.  
WO/2016/053648A1
A method for treating a low value carbon source to produce biologically labile carbon, comprising the steps of oxidizing the low value carbon source with at least one oxidizing agent to produce a modified, partially solubilized low value...  
WO/2016/050110A1
Biomarkers and methods for predicting risk of a disease in particular RA are provided. Sequences of DNA are obtained. The DNA may be extracted from a sample that is collected from a subject. A relative abundance of a biomarker is then ca...  
WO/2016/053131A1
The invention relates to the microbiology industry, microbiology and biotechnology, and specifically to the production of physiologically-active compounds, and concerns the production of the protein bacteriorhodopsin by means of micro...  
WO/2016/049936A1
The present invention provides biomarkers and methods for predicting the risk of a disease related to microbiota, in particular rheumatoid arthritis (RA).  
WO/2016/049827A1
The use of Bacteroides bacterial strains in the preparation of a formulation for the treatment and/or prevention of coronary artery disease, or for decreasing the level of blood glucose or lipids, or for ameliorating coronary atheroscler...  
WO/2016/049930A1
Biomarkers and methods for predicting the risk of a disease related to microbiota, in particular rheumatoid arthritis (RA), are provided.  
WO/2016/052174A1
The purpose of the present invention is to provide: an algae water concentration system for concentrating algae water in a culture pond into algae water containing desired sizes of algae with a single configuration, at low cost and with ...  

Matches 651 - 700 out of 94,726